Pharmaceutical Research and Manufacturers of America v. Sean O'Day, in His Official Capacity as Director of the Oregon Department of Consumer and Business Services
FirstAmendment Takings TradeSecret
Whether a state law requiring pharmaceutical manufacturers to disclose confidential trade secrets and create narrative justifications for drug pricing violates the First Amendment's protection against compelled speech and the Takings Clause's prohibition on uncompensated property seizures
and prepare the petition for filing. Additionally, the undersigned counsel has numerous other pending matters that would interfere with counsel’s ability to file the petition on or before January 21, 2026. 11. Wherefore, PhRMA respectfully requests that an order be entered extending the time to file a petition for a writ of certiorari to and including February 20, 2026. Dated: January 8, 2026 Respectfully Submitted, Allon Kedem Counsel of Record ARNOLD & PORTER KAYE SCHOLER LLP 601 Massachusetts Avenue, NW Washington, DC 20001 (202) 942-5000 Counsel for Applicant